Publisher
Springer Berlin Heidelberg
Reference53 articles.
1. Balistreri WF (1997) Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr 24:573–589
2. Bittner P, Sailer T, Posselt H-G, Bender SW, Bertele-Harms RM, Arleth S, Magdorf K, Wolf A, Krawinkel M, Ott H (1990) Behandlung der Mukoviszidose mit Ursodeoxycholsäure: Ergebnisse einer kontrollierten Doppelblindstudie. Internationales Mukoviszidose-Symposium, Titisee (Germany), October 19–21, 1990, pp 1–2
3. Bodmer MW, Angal S, Yarranton GT, Harris TJR, Lyons A, King DJ, Pieroni G, Riviere C, Verger R, Lowe PA (1987) Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim Biophys Acta 909:237–244
4. Borowitz DS, Grand RJ, Durie PR, Consensus Committee (1995) Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr 127:681–684
5. Brady MS, Rickard K, Yu P-L, Eigen H (1991) Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: a prospective randomized study. Pediatr Pulmonol 10:79–85